Murine models have shown that SD can influence the signaling of GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) by regulating Th17 and activated CD4 T cells (36), which in turn interacts with myeloid cells, exacerbating the progression of autoimmune diseases. The gene discussed is CSF2; the disease is autoimmune disease.